tti-622
pfizer
['tps8071', 'pfizer']
at #asco22, see more about the 5 cohorts in the ongoing ph 1b study evaluating dose, safety &amp; preliminary efficacy of a cd47-inhibiting fusion protein as monotherapy or in combination with other anticancer treatments in pts w/ r/r #multiplemyeloma tps8071 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ